From The Economic Times · Reuters · · 40s
Aragen Life Sciences IPO Plans $160.5m Expansion
Aragen Life Sciences aims to spend Rs 15 billion over three years on drug development and manufacturing expansion ahead of its stock market debut.
In brief
Aragen Life Sciences aims to spend Rs 15 billion over three years on drug development and manufacturing expansion ahead of its stock market debut. Aragen Life Sciences will invest Rs 15 billion over three years to expand its drug development and manufacturing capacity before its IPO. Originally reported by The…
IPO-bound Aragen expansion plans
Aragen Life Sciences plans to spend Rs 15 billion over three years for expansion.
Investment breakdown
Rs 10 billion for contract development and Rs 4 billion for discovery research.
Capacity expansion targets
Small molecules capacity to 650 kilolitres; biologics to 8.5 kilolitres by next year.
The one thing
Aragen Life Sciences will invest Rs 15 billion over three years to expand its drug development and manufacturing capacity before its IPO.
Read the TL;DR — this story on one card.



